COMMUNIQUÉS West-GlobeNewswire

Windtree Announces Istaroxime Phase 2 Interim Analysis in SCAI Stage C Cardiogenic Shock Patients
05/08/2025
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in previous trials [...]
Imprivata Introduces New Face Authentication Technology to Support Fast, Frictionless Passwordless Authentication for Frontline Workers
05/08/2025
Cutting-edge solution enables a consistent user authentication experience across devices, applications, and workflows to drive productivity while bolstering security and compliance WALTHAM, Mass., Aug. 05, 2025 (GLOBE [...]
Yatiri Bio Acquires NGeneBioAI to Expand AI-Powered Proteomics Platform and Advance Precision Biomarker Discovery
05/08/2025
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Yatiri Bio, Inc. , a leader in proteomics-driven precision medicine, today announced the successful acquisition of NGeneBioAI, Inc., a San Diego-based company specializing in [...]
Dandy Hub and Dandy Insights Help DSOs Grow Revenue, Scale Smarter
05/08/2025
New solutions give dental service organizations greater control over operations and clinical performance New Dandy offerings help DSOs streamline operations and drive revenue Dandy Hub gives DSOs a centralized portal to [...]
Zarminali Pediatrics Expands Clinical Leadership with Chief Medical Officer, Continues Network Growth Throughout United States
05/08/2025
Dr. Amanda Furr joins the national pediatric group, advancing its mission to transform the future of pediatric care for patients, parents, and providers CHICAGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics , [...]
Report: The Average Starting Salary for Physicians Exceeds $400,000
05/08/2025
Orthopedic Surgeons at the High End of the Salary Scale, Pediatricians at the Low End DALLAS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The average starting salary for physicians is $403,000, with orthopedic surgeons at the [...]
Aeroflow Health Celebrates Maine’s Tax Exemption Law on Home Medical Equipment for Its Impact on New Mothers
05/08/2025
Aeroflow marks another policy victory in its efforts to support new mothers with the passing of LD 145, which now exempts breast pumps from state sales tax on medical supplies ASHEVILLE, N.C., Aug. 05, 2025 (GLOBE [...]
HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach
05/08/2025
BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in HAM-D17 change from baseline at Week 8: -2.98; p = 0.0003) [...]
Longeveron® to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025
05/08/2025
MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging- [...]
Sienna Announces Confirmation of DBRS Credit Rating
05/08/2025
MARKHAM, Ontario, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced the confirmation by Dominion Bond Rating Service (“DBRS”) of the Company’s BBB Issuer [...]
Dogecoin Cash, Inc. Announces PrestoDoctor’s Expansion into Three New Markets
05/08/2025
Arizona, Massachusetts, and Virginia Mesquite, NV, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash, Inc. (OTCQB: DOGP), a publicly traded company focused on telehealth services and blockchain-based innovation, today [...]
Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress
05/08/2025
Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2 nd generation antisense oligonucleotide (ASO), in healthy volunteers demonstrated favorable pharmacokinetic (PK) characteristics AIC468 [...]
Amneal Reports Second Quarter 2025 Financial Results
05/08/2025
‒ Q2 2025 Net Revenue of $725 million ; GAAP Net Income of $22 million ; Diluted Income per Share of $0.07 ‒ ‒ Adjusted EBITDA of $184 million ; Adjusted Diluted EPS of $0.25 ‒ ‒ Raising 2025 Full Year Guidance ‒ ‒ Full [...]
Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts
05/08/2025
Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume growth for the first [...]
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference
05/08/2025
BOULDER, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Scott Hutton, Chief Executive Officer, and Robin Cowie, Chief Financial Officer, [...]
CorVel Announces Revenues and Earnings
05/08/2025
FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million [...]
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
05/08/2025
Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE [...]
Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
05/08/2025
– Aggregate net proceeds expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease – – Pro forma cash and cash equivalents [...]
MoonLake Immunotherapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
05/08/2025
Phase 3 VELA program in hidradenitis suppurativa (HS) on track for an expected primary endpoint readout around September 2025 and an expected submission of a Biologic License Application (BLA) in the United States in [...]

Pages